Medlab Clinical has announced the appointment of Joshua David Light as a director, effective November 19, 2024. The initial director’s interest notice reveals that Light currently holds no securities ...

Medlab Clinical (AU:MDC) has released an update. Medlab Clinical Limited reported a significant 98.7% drop in revenue, amounting to just $11,894, and a reduced net loss of $2.13 million for the year ...

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional ...

PERTH, Australia – After meeting with the FDA, Medlab Clinical Ltd. is reformulating its cannabinoid pain product into a synthetic formulation because the agency indicated it was more likely to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period. There have been no specific sales or earnings ...

PERTH, Australia – After meeting with the FDA, Medlab Clinical Ltd. is reformulating its cannabinoid pain product into a synthetic formulation because the agency indicated it was more likely to ...